Rehabtronics develops medical devices that restore function and improve the lives of people who are paralyzed or immobile. Founded in 2003 as a spinoff from the Neuroscience Institute of the University of Alberta, Rehabtronics is dedicated to bringing neuroscience discoveries into clinical practice.

The company’s newest product, Prelivia is designed to alleviate pressure injuries, one of the deadliest hospital-acquired injuries. It is the first innovation in 70 years aimed to protect patients from pressure injuries. Prelivia proprietary neurostimulation that is scientifically proven to stimulate blood circulation and minimize tissue damage.